usell.com, Inc.
PXHI
|
$1.1
|
|
Professional, Scientific, and T...
(0.0% 1d) (-9.8% 1m) (35.8% 1y) (0.0% 2d) (0.0% 3d) (-8.3% 7d) (53.85% volume)
Earnings Calendar:
Market Cap: $ 40,564,128
http://www.usell.com/
Sec Filling | Patents | 88 employees
(US) Upstart is a leading AI lending platform partnering with banks to expand access to affordable credit.
add to watch list email alert is off
HARTE HANKS INC
HHS
|
$11.47
6.5%
0.0%
|
|
Professional, Scientific, and T...
(0.0% 1d) (2.3% 1m) (33.0% 1y) (0.0% 2d) (0.0% 3d) (1.7% 7d) (1.82% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 80,521,728
https://www.hartehanks.com/
Sec Filling | Patents | 2131 employees
(US) Harte Hanks is a leading global customer experience company whose mission is to partner with clients to provide them with CX strategy, data-driven analytics and actionable insights combined with seamless program execution to better understand, attract, and engage their customers. Using its unparalleled resources and award-winning talent in the areas of Customer Care, Fulfillment and Logistics, and Marketing Services, Harte Hanks has a proven track record of driving results for some of the world's premier brands including Bank of America, GlaxoSmithKline, Unilever, Pfizer, HBOMax, Volvo, Ford, FedEx, Midea, Sony and IBM among others. Headquartered in Austin, Texas, Harte Hanks has over 2,500 employees in offices across the Americas, Europe, and Asia Pacific.
add to watch list email alert is off
Monte Rosa Therapeutics Inc
GLUE | $9.13 -3.18% 0.0% |
|
Professional, Scientific, and T...
(0.0% 1d) (18.6% 1m) (-48.2% 1y) (0.0% 2d) (0.0% 3d) (6.1% 7d) (25.83% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 441,883,381
https://www.monterosatx.com
Sec Filling | Patents | 60 employees
Monte Rosa Therapeutics is a biotechnology company discovering and developing molecular glues to degrade disease-causing proteins. The company has created a platform to rationally design small molecules that reprogram ubiquitin ligases to eliminate disease drivers previously deemed undruggable. The company’s drug discovery platform combines diverse and proprietary chemical libraries of small molecule protein degraders with in-house proteomics, structural biology, machine learning-based target selection and computational chemistry capabilities to predict and obtain protein degradation profiles. Monte Rosa was launched from founding investor Versant Ventures’ Ridgeline Discovery Engine and is headquartered in Boston, Mass., with research operations in both Boston and Basel, Switzerland.
drug discovery profitable
add to watch list email alert is off
Edenred/ADR
EDNMY
|
$27.3
|
|
Professional, Scientific, and T...
(0.0% 1d) (0.7% 1m) (21.3% 1y) (0.0% 2d) (0.0% 3d) (-1.3% 7d) (-91.15% volume)
Earnings Calendar:
Market Cap: $ 13,627,508,021
https://www.edenred.com/
Sec Filling | Patents | n/a employees
(FR)
add to watch list email alert is off
Worleyparsons Ltd/ADR
WYGPY
|
$9.59
|
|
Professional, Scientific, and T...
(0.0% 1d) (0.5% 1m) (29.6% 1y) (0.0% 2d) (0.0% 3d) (-1.4% 7d) (37.2% volume)
Earnings Calendar:
Market Cap: $ 5,035,283,166
https://www.worley.com/
Sec Filling | Patents | n/a employees
(AU)
add to watch list email alert is off
JGC Corp
JGCCY
|
$26.28
|
|
Professional, Scientific, and T...
(0.0% 1d) (-3.5% 1m) (48.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (99.47% volume)
Earnings Calendar:
Market Cap: $ 3,408,646,428
https://www.jgc.com/
Sec Filling | Patents | n/a employees
(JP)
add to watch list email alert is off
Beauty Health Company (The) - Class A
SKIN | $10.89 -1.27% 2.45% |
|
Professional, Scientific, and T...
(0.0% 1d) (3.1% 1m) (-56.3% 1y) (0.0% 2d) (0.0% 3d) (1.5% 7d) (-14.69% volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 1,559,459,336
https://www.beautyhealth.com/
Sec Filling | Patents | n/a employees
BeautyHealth is a category-creating beauty health company focused on bringing innovative products to market. Its flagship brand, HydraFacial, is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. Leading the charge in beauty health as a category-creator, HydraFacial uses a unique delivery system to cleanse, extract, and hydrate with their patented hydradermabrasion technology and super serums that are made with nourishing ingredients, providing an immediate outcome and creating an instantly gratifying glow in just three steps and 30 minutes. HydraFacial® and Perk™ products are available in over 87 countries with over 16,000 delivery systems globally and millions of treatments performed each year.
brands msa skin treatment 3d
add to watch list email alert is off
Finch Therapeutics Group Inc
FNCH | $0.93 -2.13% 0.0% |
|
Professional, Scientific, and T...
(0.0% 1d) (-12.0% 1m) (-92.0% 1y) (0.0% 2d) (0.0% 3d) (2.2% 7d) (80.31% volume)
Earnings Calendar: 2022-11-09
Market Cap: $ 44,544,838
https://finchtherapeutics.com
Sec Filling | Patents | n/a employees
Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and targeted microbiome therapeutics, Finch is advancing a rich pipeline of candidates designed to address a wide range of unmet medical needs. Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. Finch plans to initiate a Phase 3 trial, referred to as PRISM4, as its second pivotal trial of CP101 for recurrent CDI. Finch is also developing CP101 for the treatment of chronic hepatitis B virus, and FIN-211 for the treatment of the gastrointestinal and behavioral symptoms of autism spectrum disorder. In partnership with Takeda, Finch is advancing FIN-524 and FIN-525 for the treatment of ulcerative colitis and Crohn’s disease, respectively.
hepatitis gastrointestinal treatment injection
add to watch list email alert is off
ECO INNOVATION GROUP, INC.
ECOX
|
$0.0005
|
|
Professional, Scientific, and T...
(0.0% 1d) (-16.7% 1m) (-95.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-87.92% volume)
Earnings Calendar:
Market Cap: $ 548,142
Sec Filling | Patents | n/a employees
add to watch list email alert is off
3D MAKERJET, INC.
FKST | $1.7 |
|
Professional, Scientific, and T...
(0.0% 1d) (0.0% 1m) (-58.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (199.0% volume)
Earnings Calendar:
Market Cap: $ 221,360
Sec Filling | Patents | n/a employees
add to watch list email alert is off
Allied Security Innovations, Inc.
ADSV
|
$0.0002
|
|
Professional, Scientific, and T...
(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-99.87% volume)
Earnings Calendar:
Market Cap: $ 82,248
Sec Filling | Patents | 2016 employees
add to watch list email alert is off
Quantum-Si Incorporated - Class A
QSI | $2.3 -2.54% 0.42% |
|
Professional, Scientific, and T...
(0.0% 1d) (-8.5% 1m) (-64.7% 1y) (0.0% 2d) (0.0% 3d) (-5.6% 7d) (-13.16% volume)
Earnings Calendar: 2022-11-07
Market Cap: $ 275,727,439
https://quantum-si.com
Sec Filling | Patents | 115 employees
Quantum-Si Incorporated develops protein sequencing platform. The Company offers semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.
drug discovery diagnostics
add to watch list email alert is off
Integrated Cannabis Solutions, Inc.
IGPK
|
$0.0016
|
|
Professional, Scientific, and T...
(0.0% 1d) (-15.8% 1m) (-50.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-74.25% volume)
Earnings Calendar:
Market Cap: $ 2,973,307
Sec Filling | Patents | 1 employees
(US)
add to watch list email alert is off
Codex DNA Inc
DNAY | $1.34 0.0% |
|
Professional, Scientific, and T...
(0.0% 1d) (-19.8% 1m) (-81.7% 1y) (0.0% 2d) (0.0% 3d) (-1.5% 7d) (-2.91% volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 39,559,154
https://codexdna.com
Sec Filling | Patents | 101 employees
Codex DNA is a synthetic biology company focused on enabling researchers to rapidly, accurately and reproducibly build or “write” high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology enabled markets. Codex DNA’s synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA, as well as the significant limitations of existing solutions that prevent the rapid building of virtually error-free DNA and mRNA at a useable scale. A key part of Codex DNA’s solution is the BioXp™ system, an end-to-end automated workstation that fits on the benchtop and is broadly accessible due to its ease-of-use and hands-free automation. Codex DNA believes the BioXp™ system can democratize synthetic biology by simplifying the process of building DNA and mRNA, thereby accelerating the discovery, development, and production of novel high-value products, including antibody-based biologics, mRNA-based vaccines and therapeutics and precision medicines.
vaccine
add to watch list email alert is off
Inhibitor Therapeutics, Inc.
INTI
|
$0.067
|
|
Professional, Scientific, and T...
(0.0% 1d) (1.9% 1m) (-62.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-97.55% volume)
Earnings Calendar:
Market Cap: $ 25,249,508
http://www.hedgepathpharma.com/
Sec Filling | Patents | 2 employees
(US)
add to watch list email alert is off
EQRx Inc
EQRX
|
$
0%
|
|
Professional, Scientific, and T...
(0% volume)
Earnings Calendar:
Market Cap:
Sec Filling | Patents | n/a employees
add to watch list email alert is off
AccuStem Sciences Ltd
ACMSY | $0.13 0% |
|
Professional, Scientific, and T...
(0.0% 1d) (4.0% 1m) (-31.6% 1y) (4.0% 2d) (4.0% 3d) (0.0% 7d) (13.9% volume)
Earnings Calendar:
Market Cap:
Sec Filling | Patents | n/a employees
add to watch list email alert is off
Design Therapeutics Inc
DSGN | $13.52 -1.1% 0.0% |
|
Professional, Scientific, and T...
(0.0% 1d) (-11.1% 1m) (-26.3% 1y) (0.0% 2d) (0.0% 3d) (-2.1% 7d) (-4.02% volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 755,904,160
https://www.designtx.com
Sec Filling | Patents | n/a employees
Design Therapeutics is a biotechnology company developing a new class of therapies based on a platform of gene targeted chimera (GeneTAC™) small molecules. The company’s lead program is focused on the treatment of Friedreich ataxia, followed by a program in myotonic dystrophy type-1 and discovery efforts for multiple other serious degenerative disorders caused by nucleotide repeat expansions.
treatment
add to watch list email alert is off
Capita Group/ADR
CTAGY
|
$1.17
|
|
Professional, Scientific, and T...
(0.0% 1d) (0.0% 1m) (-53.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-54.67% volume)
Earnings Calendar:
Market Cap:
https://www.capita.com/
Sec Filling | Patents | n/a employees
(United Kingdom)
add to watch list email alert is off
Gene Biotherapeutics, Inc.
CRXM
|
$0.0001
0%
|
|
Professional, Scientific, and T...
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-70.0% volume)
Earnings Calendar:
Market Cap:
http://www.cardiumthx.com/
Sec Filling | Patents | n/a employees
(US)
add to watch list email alert is off
Your Today's Watch List
Sign in to create a watchlistTop 10 Gainers
|
Finance
MSC | $3.98 21.01% 11.81% |
|
Consumer Services
CCM | $1.63 9.82% |
|
Health Services
UPH 4 | $0.2341 -28.85% 8.93% |
|
Professional, Scientific, and T...
ID 4 | $1.08 -6.09% 8.8% |
|
Finance
DTC 4 | $4.28 -2.51% 8.41% |
|
Manufacturing
IMH | $0.231 -5.64% 8.23% |
|
Finance
IGC | $0.4095 -9.0% 7.2% |
|
Health Technology
GROY | $2.56 -1.16% 6.48% |
|
Mining, Quarrying, and Oil and ...
GLDG | $1.24 -12.06% 6.45% |
|
Non-Energy Minerals
Last 48 Hours Insiders Buying
BOXL P 32000 | $0.3124 -12.98% 2.51% |
|
Commercial Services
|
01:00
FRST P | $12.12 0.0% |
|
Finance and Insurance
|
00:30
SDPI P 16279 | $0.8052 -1.2% -0.65% |
|
Industrial Services
|
23:00
STRR P 10000 | $0.97 3.09% |
|
Manufacturing
|
23:00
PED P 76746 | $1.1 0.0% |
|
Industrial Services
|
22:50
KRO P 2000 | $9.57 1.59% 0.0% |
|
Process Industries
|
22:00
NL P 2000 | $6.75 -1.6% 0.0% |
|
Producer Manufacturing
|
22:00
IDN P 1796 | $2.08 0.0% |
|
Electronic Technology
|
22:00
VHI P 1000 | $23.75 -4.89% 0.0% |
|
Process Industries
|
22:00
RHE P 7200 | $2.69 1.32% 0.37% |
|
Finance
|
21:50
CIX P 1000 | $18.6 -2.26% 0.0% |
|
Producer Manufacturing
|
21:50
FMBM P 54 | $22.69 |
|
Finance and Insurance
|
21:10
HSON P 1000 | $24.99 -0.28% 0.0% |
|
Commercial Services
|
21:10
ELA P 2500 | $5.23 -0.95% 0.19% |
|
Retail Trade
|
17:30
NYCB P 6000 | $8.63 1.17% -0.7% |
|
Finance
|
16:50
HPKEW 4 | $16.2197 0% |
|
Industrial Services
|
23:50